Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL

/PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to...

Related Keywords

China ,United States ,Suzhou ,Jiangsu ,American ,Stephanie Carrington ,Martina Sersch ,Marvin Tang ,Kyle Evans ,Prnewswire Gracell Biotechnologies Inc ,Gracell Biotechnologies Inc ,Nasdaq ,Orleans Convention Center ,Exchange Commission ,American Association For Cancer Research ,American Cancer Society ,American Association ,Cancer Research ,Annual Meeting ,Chief Medical Officer ,Phasei Clinical Trials ,New Orleans Convention Center ,Exhibit Hallsd H ,Poster Section ,Board Number ,Abstract Number ,Itinerary Planner ,Private Securities Litigation Reform Act ,American Cancer ,Gracell ,